Three stocks benefiting from the cannabis boom, even though they … – Financial Post

As the legalization of recreational marijuana in Canada next summer draws closer, investors have been piling into cannabis-cultivating companies, driving the shares of producers such as Canopy Growth Corp. and Aphria Inc. up more than 100 per cent over the past 12 months.

There is, however, more to the burgeoning industry than simply growing plants.

A Deloitte study on Canada’s coming recreational market predicted that sales could reach as much as $8.7 billion per year, but noted that the money from ancillary activities could boost the economic impact to more than $22.6 billion.

As a result, companies designed to support, service and supplement the sector are also seeing their shares bid up to unprecedented levels.
With that in mind, here are three fast-moving marijuana stocks that don’t necessarily grow marijuana:

Neptune Technologies & Bioressources Inc.

Medical marijuana is already legal in Canada, and Quebec-based Neptune, a manufacturer of nutritional supplements, is jumping into the market.

Neptune said in late November that it was now extending a licensing agreement for the use of its “patented omega-3 fatty acid delivery technology” in connection with products derived from cannabis.

“We will now begin investigating the impact of this innovative technology on the absorption and benefits of cannabis and cannabinoid ingredients,” said Jim Hamilton, chief executive of Neptune, in a release. The company says it has also applied for a licence to produce cannabis oil.

Echelon Wealth Partners said in a note that Neptune “is already exploring creative ways to marry cannabis oil with existing expertise in nutritional supplement co-formulation and distribution.”

“We also see no reason why oil-based cannabinoid formulations sold into nutritional/medical markets cannot grow as rapidly as recreational markets, if not faster,” wrote analyst Douglas Loe.

Shares of Neptune are up more than 65 per cent this year on the TSX,

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Comments Off on Three stocks benefiting from the cannabis boom, even though they … – Financial Post

Here's What Caused This Marijuana Stock to Skyrocket 15% in … – Motley Fool

What happened

Medical marijuana has been used to treat epilepsy in patients for years, but so far, it’s efficacy and safety hasn’t been supported by a regulatory green light from the Food and Drug Administration (FDA). Based on recently reported results for Epidiolex, a cannabidiol epilepsy medicine, that could be about to change.

Updated trial results released last month show that Epidiolex helps patients with rare epilepsy on its own, and treatment results may improve with long-term use. That news caused shares of Epidiolex’s drug developer, GW Pharmaceuticals (NASDAQ:GWPH), to jump 15.3% in November, according to S&P Global Market Intelligence.

So what

After demonstrating that Epidiolex can reduce the rate of monthly seizures by around 40%, GW Pharmaceuticals recently filed Epidiolex for FDA approval in Dravet syndrome and Lennox-Gastaut syndrome, two rare forms of pediatric-onset epilepsy.

IMAGE SOURCE: GW PHARMACEUTICALS.

In November, the medical-marijuana company strengthened the likelihood of an FDA green light by unveiling additional trial results showing that 35% of Lennox-Gastaut syndrome patients responded to Epidiolex monotherapy, but only 13% of patients responded to a placebo. There has been some debate over how much of Epidiolex’s efficacy was tied to its use alongside clobazom, a common epilepsy medicine, and the risk of drug interactions, so the monotherapy data is important.

Results from Epidiolex’s long-term extension study also show that patient response to Epidiolex continues to be impressive. In Dravet syndrome patients, Epidiolex reduced total monthly seizures by 57% to 59% from baseline at week 60. In Lennox-Gastaut syndrome patients, it reduced monthly seizures by 62% to 70% from baseline at week 60. 

Now what

GW Pharmaceuticals only markets one marijuana medicine currently, and sales of that drug, Sativex, are a rounding error. Therefore, an approval of Epidiolex in Dravet syndrome and Lennox-Gastaut syndrome is critical to improving this company’s financials.

There aren’t many patients

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Comments Off on Here's What Caused This Marijuana Stock to Skyrocket 15% in … – Motley Fool

Canada now has a third pot stock worth more than $2-billion – The Globe and Mail

There’s another cannabis stock that has breached the $2-billion mark in market capitalization.

Shares of grower Aphria Inc. soared 16 per cent and to new highs on Tuesday, closing at $13.53. The rally pushed Aphria’s market cap to just over $2-billion. The Leamington, Ont.-based company is joining the likes of Canopy Growth Corp. and Aurora Cannabis Inc., whose stocks are worth $3.6-billion and $3-billion, respectively.

Investors piled into Aphria’s stock a day after the company said it will supply Canada’s largest pharmacy chain with medical marijuana.

Story continues below advertisement

The deal will see Aphria supply both dried bud and oils to Shoppers Drug Mart, which is owned by retailer Loblaw Cos. Ltd. Shoppers is looking to sell the drug to patients through an online portal and has applied to Health Canada for a license to do so. By law, the drug can be distributed to users through the mail.

The tie-up with Aphria is a sign that larger retailers want to sell medical marijuana, meaning that patients may soon have greater access to the drug. One analyst called the deal “a watershed moment for the industry.” Another said that it is “a major milestone for Aphria and for the sector at large.”

Aphria has seen the value of its shares more than double since mid-October amid a frenzy around pot stocks.

Many analysts who cover Aphria have raised their 12-month target price for the stock, pushing the average price from a little over $10 a share to just over $13, which is still below Tuesday’s closing price of $13.53. Seven analysts have rated the company’s stock a buy. One analyst says it’s a hold.

Canada’s legal cannabis market is young but growing up fast. The last watershed moment for the industry

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Comments Off on Canada now has a third pot stock worth more than $2-billion – The Globe and Mail

Bitcoin Fever Makes Pot Stocks Yesterday's News in Canada – Bloomberg

The country that brought you the first marijuana unicorn is plunging headlong into the next big thing: cryptocurrencies.

Little-known Canadian stocks such as Hive Blockchain Technologies Ltd., Glance Technologies Inc., and NetCents Technology Inc. have surged as much as 20-fold this year, giving retail investors a way to embrace the mania without actually having to buy bitcoins. 

The country counts at least eight cryptocurrency-related stocks with a market value totaling about C$2 billion ($1.6 billion), making it a burgeoning hub for bitcoin listings. And there may be more ways to invest soon: At least two Canadian firms have filed to launch what could be among the first bitcoin exchange-traded funds.

Canada’s stock markets are no strangers to investing fads, with cobalt, lithium and marijuana stocks all bubbling higher this year. The country’s TSX Venture Exchange has been dubbed the “wild west,” the penny stocks among its more than 1,700 listings gyrating wildly from one day to the next.

Cryptocurrency experts say the fast-evolving bitcoin sector is a classic case of buyer beware, not unlike the dot-com bubble of the late 1990s when shares would spike in value simply because a company had “.com” in its name. Bitcoin, one of several digital currencies, briefly topped $11,000 on Nov. 29 and was trading at about $10,780 on Friday, up roughly 11-fold this year.

“There is an arbitrage that comes from being a public company with ‘something blockchain’ in the name,” said Lex Sokolin, global director of fintech strategy at Autonomous Research LLP in London. “The demand is really high for anything crypto and the supply is very low, so you’re not really winning on your merit, you’re just winning because of the market dynamic.”

Read More: Understanding Bitcoin’s Rise, $0.01 to $11,000:

The market is crying out for

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Comments Off on Bitcoin Fever Makes Pot Stocks Yesterday's News in Canada – Bloomberg

Trade of the Day: Potash Corporation of Saskatchewan (USA) Is a Breakout Candidate – Investorplace.com

Popular Posts: Recent Posts:

Shares of materials company Potash Corporation of Saskatchewan (USA) (NYSE:POT) are higher by just shy of 10% for the year and have likely frustrated plenty of traders of late. But a look at the charts with some perspective reveals a bullish pattern in multiple time frames, and thus one that in my eye that has much potential for higher prices in the near to intermediate term.

The materials sector of stocks of the S&P 500 as represented by the Materials Select Sector SPDR (NYSEARCA:XLB) exchange-traded fund for 2017 remains in a firm bull trend, which, in recent  months, has been aided by a bid in the energy commodities. While certainly not all materials stocks are created equal, it is nice to see a general bull trend in the underlying sector.

POT Stock Charts


Click to Enlarge

Moving averages legend: red – 200 week, blue – 100 week, yellow – 50 week

For some perspective on shares of Potash itself, let’s look at the multiyear weekly chart. Here we see a stock that, after topping out in the year 2008, has since only managed to make a series of lower highs. POT stock has largely been basing since early 2016 through this lens and while still in the larger picture down-trend, from a momentum perspective it is certainly beginning to look more promising.

No cigar in this time frame just yet to be sure, but the grizzly bears on this stock would be wise to watch how the next few weeks or months unfold for a trend change from intermediate term bearish to intermediate-term bullish does look increasingly likely.


Click to Enlarge

Moving averages legend: red – 200 day, blue – 100 day, yellow – 50 day

Over on the daily chart, things look decisively more

Read More Here...

Posted in Hemp, MMJ, Cannabis Stocks News | Comments Off on Trade of the Day: Potash Corporation of Saskatchewan (USA) Is a Breakout Candidate – Investorplace.com
« Older
Newer »